In a study by Cavdar et al., the relationship between OS and inflammatory markers such as NLR, PLR, SII, HALP, and the advanced lung cancer inflammation index (ALI) was examined in 278 patients with metastatic NSCLC. The gene discussed is NAT10; the disease is lung cancer.